mHealth Insiders Differ On When Software Apps Should Face FDA Regs
This article was originally published in The Gray Sheet
Executive Summary
Place a small group of experts and stakeholders together in one Washington, D.C., conference room, and you will get a split – almost down the middle – in opinion over whether any given mobile health application should fall under FDA authority.
You may also be interested in...
Cloud Computing Could Complicate Efforts To Clarify Mobile Health Regulation
Advances in cloud computing – where data storage or processing tasks for a software application are distributed among multiple remote computer networks – are adding a new wrinkle to industry’s efforts to draft a mobile health regulatory guidance document for FDA review.
Cloud Computing Could Complicate Efforts To Clarify Mobile Health Regulation
Advances in cloud computing – where data storage or processing tasks for a software application are distributed among multiple remote computer networks – are adding a new wrinkle to industry’s efforts to draft a mobile health regulatory guidance document for FDA review.
Third Time's A Charm: Long Road To First 510(k)-Cleared Mobile Imaging App
Executives at MIM Software were working through last-minute operational bumps last week in bringing their Mobile MIM software application to the Apple Apps Store – two and a half years after FDA told the firm it could not market the medical imaging management tool without the agency's OK.